ABIVAX Société Anonyme (EPA:ABVX)
5.80
+0.05 (0.87%)
Apr 1, 2025, 12:44 PM CET
ABIVAX Société Anonyme Employees
ABIVAX Société Anonyme had 69 employees as of December 31, 2024. The number of employees increased by 8 or 13.11% compared to the previous year.
Employees
69
Change (1Y)
8
Growth (1Y)
13.11%
Revenue / Employee
€156,406
Profits / Employee
€2,554,232
Market Cap
364.45M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Sanofi | 82,878 |
EssilorLuxottica Société anonyme | 153,498 |
Sartorius Stedim Biotech | 9,901 |
bioMérieux | 14,754 |
Eurofins Scientific SE | 62,696 |
Ipsen | 5,358 |
Virbac | 5,620 |
emeis Société anonyme | 77,954 |
ABIVAX Société Anonyme News
- 4 days ago - ABIVAX: Undercovered, Late-Stage French Company With Upcoming Catalysts - Seeking Alpha
- 5 days ago - Abivax publishes financial reports with the French and U.S. securities regulatory agencies - GlobeNewsWire
- 7 days ago - Abivax reports FY results - Seeking Alpha
- 8 days ago - Abivax Announces Full Year 2024 Financial Results - GlobeNewsWire
- 5 weeks ago - Abivax to Host Key Opinion Leader (KOL) Webcast on March 17, 2025 - GlobeNewsWire
- 2 months ago - Abivax Publishes 2025 Financial Calendar - GlobeNewsWire
- 2 months ago - Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn's and Colitis Organization 20th Annual Congress - GlobeNewsWire
- 2 months ago - Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment - GlobeNewsWire